abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

์ด ํŽ˜์ด์ง€๋Š” ํ•œ๊ตญ์–ด๋กœ ์ œ๊ณต๋˜์ง€ ์•Š์œผ๋ฉฐ English๋กœ ํ‘œ์‹œ๋ฉ๋‹ˆ๋‹ค.

๊ธฐ์—… ์‘๋‹ต

2006๋…„ 9์›” 13์ผ

Response by Bristol-Myers Squibb: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Bristol-Myers Squibb - finds none has comprehensive approach.

์ด๋Š” ๋‹ค์Œ์— ๋Œ€ํ•œ ์‘๋‹ต์ž…๋‹ˆ๋‹ค

Interfaith Center on Corporate Responsibility - new report on pharmaceutical firms' responses to AIDS

์ด์•ผ๊ธฐ 2006๋…„ 8์›” 14์ผ

ํƒ€์ž„๋ผ์ธ